CD Biosynsis has a scientific team dedicated to the study of protozoa, aiming to explore their potential as synthetic biology chassis and create new possibilities in biotechnology and medicine. We help our customers develop genetic tools and synthetic biology methodologies to establish more model organisms for studying protozoa and evaluate their potential applications in fundamental biological studies and different industries.
The rapid development of synthetic biology is often limited by the lack of options in terms of chassis. Looking beyond the tradational synthetic biology chassis towards the abundant organisms in nature that may poss desirable physiological features and functions is a promising strategy. Protozoa represent an attractive untapped source of synthetic biology chassis because they are highly evolutionarily divergent from the more commonly used bacterial, fungal, and mammalian cells. Protozoa with fast doubling times and ease of culture have recently emerged as a novel manufacturing platform for biotherapeutics, such as recombinant subunit vaccines. Trypanosoma brucei, as a model organism, has been established as the first and a promising novel synthetic biology chassis in the phylum Protozoa. It is believed that the birth of the Protist 10,000 Genomes Project and the establishment of synthetic biology approaches in protozoa will greatly expand our understanding of protozoa and enhance their industrial capabilities.
CD Biosynsis has built a team of scientists focused on the study of diversity, evolution, cytology, molecular biology, epigenetics, and pathobiology of protozoa. We work on developing genetic tools and synthetic biology approaches to enhance the capability of protozoa as new synthetic biology chassis, laying the foundation for future applications of synthetic biology. Our expanding synthetic biology toolbox allows us to provide more comprehensive support to our customers.
|Synthetic Biology Toolbox in Protozoa|
|Genetic tools||DNA integration, particle bombardment, electroporation, gene editing using programmable nucleases (ZFN, TALENs, RGEN), CRISPR/Cas9 system, RNA interference (RNAi), transient and stable transfection, etc.|
|Omics tools||Genomics, transcriptomics, proteomics, metabolomics, lipidomics, epigenomics, glycomics, fluxomics, phenomics, databases, etc.|
Protozoa have long been useful models for diverse fields, including genetics, cell biology, evolutionary biology, ecology, pathology, and toxicology. With the intensive study of protozoa, CD Biosynsis has tried to establish protozoa such as Trypanosoma brucei, the social amoeba Dictyostelium discoideumas, and Eimeria tenella as synthetic biology chassis. Our scientists have also been working to explore the synthetic biology potential of other types of protozoa (e.g., ciliates). Protozoa as synthetic biology chassis are expected to open up new possibilities for the following applications.
CD Biosynsis has been continuously expanding our synthetic biology toolbox and keeping our knowledge and skills current. We provide full support for our customers' innovations in synthetic biology. If you require any further details, please feel free to contact us and let us know how we can support your new idea or project.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.